Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03868150
Other study ID # 38527
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date March 1, 2017
Est. completion date December 31, 2050

Study information

Verified date November 2023
Source Stanford University
Contact Anson Lee, MD
Phone 650-724-7500
Email ansonlee@stanford.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients undergoing first time cardiac surgery will undergo rapid atrial pacing prior to initiation of cardiopulmonary bypass to screen for AF inducibility. Patients with inducible AF will be randomized to prophylactic amiodarone treatment versus no treatment. Patients who are not inducible to AF will be treated with standard post-operative care. Patients will be monitored post-operatively to explore the value of intraoperative inducibility of AF to predict POAF and to evaluate whether the combination of intraoperative inducibility and precision amiodarone therapy is effective at reducing the incidence of POAF


Description:

In the operating room, as part of the open heart surgery, the surgeon will stimulate the superior right atrium section of the heart with a pacemaker for 30 seconds just prior to starting the heart and lung bypass machine. The stimulation is done to see how sensitive the heart is to developing atrial fibrillation. This test result will be documented. The procedure will only take 60 seconds out of the entire operation. It does not involve taking any samples of tissue or blood. Following this step, if the heart demonstrates atrial fibrillation for at least 30 seconds then the participant will then be randomized to either receive the prophylactic drug treatment using Amiodarone or to no prophylactic drug administration. The participant has a 50% chance of receiving the FDA approved study drug Amiodarone. The study arms consist of prophylactic drug administration with Amiodarone, No prophylactic drug administration, or no atrial fibrillation reaction after stimulation with the pacemaker. The remainder of the surgical procedure will not be affected, and will follow routine surgical practice.


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date December 31, 2050
Est. primary completion date December 31, 2030
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients scheduled for first-time non-emergent open-heart surgery for coronary artery bypass graft (CABG) revascularization, valvular repair or replacement, combined CABG with valve repair or replacement, or valve sparing aortic root repair - Normal sinus rhythm - No documented history of atrial fibrillation Exclusion Criteria: - Prior surgical procedures involving heart surgery and cardiopulmonary bypass - Any prior documented history of atrial fibrillation, atrial flutter or atrial tachycardia lasting longer than 30 seconds - Prior history of Amiodarone treatment for the management of supraventricular tachy-arrhythmias - Patients requiring surgical treatment of atrial arrhythmias such as pulmonary vein isolation or Maze procedure.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Amiodarone Injection
Patients stratified into the amiodarone study group were administered amiodarone until day of discharge. Amiodarone administration began intraoperatively with the administration of a 150 mg IV amiodarone loading bolus prior to separation from coronary pulmonary bypass, followed by 1 mg/min IV amiodarone for six hours (360 mg), then 0.5 mg/min IV amiodarone for 18 hours (540 mg), then transitioned to 400 mg oral amiodarone twice a day until discharge. In total, patients in the amiodarone treatment group received 1,050mg of IV amiodarone plus 800mg/day of oral amiodarone thereafter until discharge.
Device:
Intraoperative Rapid Atrial Pacing
Intraoperative rapid atrial pacing for 30 seconds after cannulation and prior to initiation of cardiopulmonary bypass by having the surgeon attach insulated forceps to the superior right atrial free wall and connected to a temporary pacemaker to burst pace at a rate of 800 bpm for 30 seconds (pulse width 1.0 ms, output: 20 mA) Patients are monitored for successful atrial fibrillation induction defined as 30 seconds of sustained atrial fibrillation on ECG.

Locations

Country Name City State
United States Stanford University Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Decreasing the incidence of Post-Operative Atrial Fibrillation for Cardiac Surgery Patients Identify predictors of developing atrial fibrillation in the hope of decreasing post-operative length of stay, the need for anticoagulation, decrease risk of stroke, DVT, and bleeding 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT03857711 - Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation) N/A
Completed NCT02132767 - Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation Phase 3
Completed NCT01742039 - Prevention of Postoperative Atrial Fibrillation
Recruiting NCT06151652 - Effect of Alpha-Lipoic Acid Supplementation on the Incidence of Postoperative Atrial Fibrillation in Cardiac Surgery Patients Phase 4
Recruiting NCT05076019 - Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement N/A
Completed NCT03646773 - Microvascular Effects of Intravenous Esmolol During Postoperative Atrial Fibrillation
Completed NCT00765089 - Bipolar Radiofrequency Ablation -Role in Prevention of Postoperative Atrial Fibrillation Phase 4
Recruiting NCT05730413 - Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery Phase 4
Completed NCT04307225 - Atrial Fibrillation After CABG and PCI
Completed NCT05009914 - A New Way of Cardiac Denervation to Reduce the Incidence of AF After CABG. N/A
Recruiting NCT03905759 - Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG Phase 2/Phase 3
Recruiting NCT06054360 - Predictive Value of Right Atrial Strain in Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Recruiting NCT05320705 - The Effect of Intra Operative Dexmedetomidine in Prevention of Early Postoperative Atrial Fibrillation Phase 1
Recruiting NCT05062239 - Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins N/A